The Royal Children's Hospital Melbourne
Welcome,         Profile    Billing    Logout  
 9 Trials 
19 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inaba, Hiroto
NCT03117751: Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

Active, not recruiting
2/3
790
US, RoW
Prednisone, Prednisolone, Deltasone, Meticorten, Orasone®, Liquid Pred, Pediapred®, Sterapred®, Vincristine, Vincristine sulfate, Oncovin®, VCR, LCR, Daunorubicin, Daunomycin, rubidomycin, Cerubidine®, Pegaspargase, PEG-asparaginase, PEGLA, PEG-L-asparaginase, polyethylene glycol-L-asparaginase, Oncaspar®, Erwinase®, Erwinia chrysanthemi, Asparaginase Erwinia chrysanthemi, Erwinaze^TM, Crisantaspase, Cyclophosphamide, Cytoxan®, Cytarabine, Cytosine arabinoside, Ara-C, Cytosar®, Mercaptopurine, 6-MP, Purinethol®, Purixan^TM, 6-mercaptopurine, Dasatinib, Sprycel®, Methotrexate, MTX, amethopterin, Trexall®, Blinatumomab, Blincyto®, Ruxolitinib, Jakafi®, Bortezomib, Velcade®, Dexamethasone, Decadron®, Hexadrol®, Dexone®, Dexameth®, Doxorubicin, Adriamycin®, Etoposide, Etoposide Phosphate, VePesid®, Etopophos®, VP-16, Clofarabine, Clolar®, Vorinostat, Zolinza®, Suberoylanilide Hydroxamic Acid, SAHA, Idarubicin, Idarubicin HCl, 4-Demethoxydaunorubicin, 4-DMD, DMDR, Idamycin PFS®, Nelarabine, Arranon®, Atriance®, Compound 506U78, Thioguanine, 6-thioguanine, Tioguanine, 2-amino-1,7-dihydro-6H-purine-6-thione, WR-1141, Tabloid®, Lanvis®, Asparaginase Erwinia chrysanthemi (recombinant)-rywn, Rylaze™, Recombinant Erwinia, Calaspargase Pegol, ASPARLAS
St. Jude Children's Research Hospital, Incyte Corporation, Amgen, Servier
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma
09/26
03/28
NCT05955261: A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

Recruiting
2
70
US
Venetoclax, Venclextra, ABT-99, Azacitidine, Mylosar, Vidaza, Cytarabine, Ara-C, Cytosar-U®, Gemtuzumab Ozogamicin, Mylotarg, Daunorubicin Hydrochloride, FI-6339, L-lyxo-Hexopyranoside, Fludarabine Phosphate, SH T 586, Idarubicin Hydrochloride, IMI-30, Zavedos, Mitoxantrone Hydrochloride, Neotalem, Pralifan, Novantrone, Etoposide, VP-16, Vepesid®, Gilteritinib, Xospata
St. Jude Children's Research Hospital, AbbVie
Acute Myeloid Leukemia
12/26
03/34
NCT06177067: Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Recruiting
1
24
US
Revumenib, SNDX-5613, Venetoclax, Venclextra®, Azacitidine, VIDAZA®, 5-azacitidine, intrathecal (IT) chemotherapy, ITMHA, methotrexate/hydrocortisone/cytarabine, Cytarabine, Ara-C, Cytosar®, Methotrexate, MTX, Trexall®
St. Jude Children's Research Hospital, Syndax Pharmaceuticals
Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Leukemia of Ambiguous Lineage
01/26
07/26
NCT05918913: Expanded Access Program for Revumenib

Available
N/A
US
Revumenib, SNDX-5613
Syndax Pharmaceuticals
Relapsed/Refractory Acute Leukemia
 
 
Lim, Lyndell
ADVISE, NCT03828019: Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

Active, not recruiting
3
222
Europe, Canada, US, RoW
Adalimumab (ADA), Adalimumab, Humira, Conventional immunosuppression (CON), Azathioprine, Imuran , Cyclosporine, Methotrexate, Rheumatrex, Mycophenolate, CellCept, Cyclosporine, Sandimmune, Neoral, Tacrolimus, Prograf
JHSPH Center for Clinical Trials
Uveitis
04/24
09/24
ACTRN12611000888965: Avastin versus Triamcinolone for Diabetic Macular Edema at the time of Cataract Surgery

Recruiting
2
100
 
Royal Victorian Eye and Ear Hospital
Diabetic Macular Oedema, Cataracts
 
 
ACTRN12607000315415: Avastin in the treament of Macular oedema and Uveitis

Not yet recruiting
N/A
20
 
Royal Victorian Eye and Ear Hospital, Royal Victorian Eye and Ear Hospital Research Fund
1. Macular oedema secondary to diabetic retinopathy , 2. Macular oedema secondary to uveitis , 3. Subfoveal choroidal neovascularisation (CNV) secondary to uveitis
 
 
Vickery, Brian
OUtMATCH, NCT03881696: Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

Hourglass Jul 2023 - Dec 2023 : Data readout from P3 OUtMATCH trial for food allergy
Active, not recruiting
3
471
US
Omalizumab, Xolair®, Placebo for Omalizumab, Placebo, Multi-Allergen Oral Immunotherapy, Multi-Allergen OIT, Placebo for Multi-Allergen Oral Immunotherapy, Placebo for Multi-Allergen OIT, Double-Blind Placebo-Controlled Food Challenge Based Treatment, DBPCFC Based Treatment
National Institute of Allergy and Infectious Diseases (NIAID), Genentech, Inc., Novartis Pharmaceuticals, Rho Federal Systems Division, Inc.
Peanut Allergy, Multi-food Allergy
03/23
06/25
NCT05621317: A Safety and Efficacy Study of PVX108 in Children and Adolescents with Peanut Allergy

Active, not recruiting
2
90
US, RoW
PVX-108, Placebo
Aravax Pty Ltd
Peanut Allergy, Peanut Hypersensitivity, Peanut-Induced Anaphylaxis, Immune System Diseases
11/25
06/27
adored, NCT05003804: Allergic Disease Onset Prevention Study

Active, not recruiting
1/2
264
US, RoW
STMC-103H, Placebo
Siolta Therapeutics, Inc.
Atopic Dermatitis, Type 1 Hypersensitivity
11/24
10/25
Ibrahim, Laila F
CHOICE UTI, NCT04876131: Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children

Recruiting
4
452
RoW
Benzylpenicillin - single dose, Benzylpenicillin - three days, Gentamicin - single dose, Gentamicin - three days, Cefalexin - post single dose of IV antibiotics for the remaining two days
Murdoch Childrens Research Institute, Royal Children's Hospital
Complicated Urinary Tract Infection, Infection, Pediatric Infectious Disease
05/28
05/28
Khaw, Seong Lin
NCT03117751: Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

Active, not recruiting
2/3
790
US, RoW
Prednisone, Prednisolone, Deltasone, Meticorten, Orasone®, Liquid Pred, Pediapred®, Sterapred®, Vincristine, Vincristine sulfate, Oncovin®, VCR, LCR, Daunorubicin, Daunomycin, rubidomycin, Cerubidine®, Pegaspargase, PEG-asparaginase, PEGLA, PEG-L-asparaginase, polyethylene glycol-L-asparaginase, Oncaspar®, Erwinase®, Erwinia chrysanthemi, Asparaginase Erwinia chrysanthemi, Erwinaze^TM, Crisantaspase, Cyclophosphamide, Cytoxan®, Cytarabine, Cytosine arabinoside, Ara-C, Cytosar®, Mercaptopurine, 6-MP, Purinethol®, Purixan^TM, 6-mercaptopurine, Dasatinib, Sprycel®, Methotrexate, MTX, amethopterin, Trexall®, Blinatumomab, Blincyto®, Ruxolitinib, Jakafi®, Bortezomib, Velcade®, Dexamethasone, Decadron®, Hexadrol®, Dexone®, Dexameth®, Doxorubicin, Adriamycin®, Etoposide, Etoposide Phosphate, VePesid®, Etopophos®, VP-16, Clofarabine, Clolar®, Vorinostat, Zolinza®, Suberoylanilide Hydroxamic Acid, SAHA, Idarubicin, Idarubicin HCl, 4-Demethoxydaunorubicin, 4-DMD, DMDR, Idamycin PFS®, Nelarabine, Arranon®, Atriance®, Compound 506U78, Thioguanine, 6-thioguanine, Tioguanine, 2-amino-1,7-dihydro-6H-purine-6-thione, WR-1141, Tabloid®, Lanvis®, Asparaginase Erwinia chrysanthemi (recombinant)-rywn, Rylaze™, Recombinant Erwinia, Calaspargase Pegol, ASPARLAS
St. Jude Children's Research Hospital, Incyte Corporation, Amgen, Servier
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma
09/26
03/28
WUC007-03, NCT06514794: A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy inT-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Recruiting
2
125
US, RoW
WU-CART-007
Wugen, Inc.
T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
12/26
12/28
APAL2020SC, NCT04726241: The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Recruiting
1/2
960
Canada, US, RoW
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection
LLS PedAL Initiative, LLC, Children's Oncology Group, National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, Juvenile Myelomonocytic Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome Post Cytotoxic Therapy, Myeloid Leukemia Associated With Down Syndrome
12/26
12/26
Troutbeck, Robyn
INSITE-DME, NCT05610319: Treat & Extend Versus Fixed Dosing with Faricimab for Management of Diabetic Macular Edema: a Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

Active, not recruiting
4
446
Europe, Canada, US, RoW
Faricimab
McMaster University, Hoffmann-La Roche
Diabetic Macular Edema
12/26
12/26
NCT03816397: Adalimumab in JIA-associated Uveitis Stopping Trial

Active, not recruiting
4
118
Europe, US, RoW
Adalimumab, HUMIRA, Placebo
Nisha Acharya, Children's Hospital of Philadelphia, Children's Hospital Medical Center, Cincinnati, Children's Mercy Hospital Kansas City, National Eye Institute (NEI), Great Ormond Street Hospital for Children NHS Foundation Trust, University Hospitals Bristol and Weston NHS Foundation Trust, Alder Hey Children's NHS Foundation Trust, Newcastle-upon-Tyne Hospitals NHS Trust, Sheffield Children's NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Royal Children's Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Vanderbilt University Medical Center, University of California, Davis, University of Texas at Austin, University of Miami, University Hospitals, Leicester, University of Utah, Colorado Retina Associates, Manchester University NHS Foundation Trust
Uveitis, JIA
04/25
07/25
Renton, William
NCT03816397: Adalimumab in JIA-associated Uveitis Stopping Trial

Active, not recruiting
4
118
Europe, US, RoW
Adalimumab, HUMIRA, Placebo
Nisha Acharya, Children's Hospital of Philadelphia, Children's Hospital Medical Center, Cincinnati, Children's Mercy Hospital Kansas City, National Eye Institute (NEI), Great Ormond Street Hospital for Children NHS Foundation Trust, University Hospitals Bristol and Weston NHS Foundation Trust, Alder Hey Children's NHS Foundation Trust, Newcastle-upon-Tyne Hospitals NHS Trust, Sheffield Children's NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Royal Children's Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Vanderbilt University Medical Center, University of California, Davis, University of Texas at Austin, University of Miami, University Hospitals, Leicester, University of Utah, Colorado Retina Associates, Manchester University NHS Foundation Trust
Uveitis, JIA
04/25
07/25
Perrett
NCT05621317: A Safety and Efficacy Study of PVX108 in Children and Adolescents with Peanut Allergy

Active, not recruiting
2
90
US, RoW
PVX-108, Placebo
Aravax Pty Ltd
Peanut Allergy, Peanut Hypersensitivity, Peanut-Induced Anaphylaxis, Immune System Diseases
11/25
06/27
O'Sullivan
NCT05621317: A Safety and Efficacy Study of PVX108 in Children and Adolescents with Peanut Allergy

Active, not recruiting
2
90
US, RoW
PVX-108, Placebo
Aravax Pty Ltd
Peanut Allergy, Peanut Hypersensitivity, Peanut-Induced Anaphylaxis, Immune System Diseases
11/25
06/27

Download Options